Alyeska Investment Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Alyeska Investment Group’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-538,579	Closed	-$3.15M	–	559
2022 Q4	$3.15M	Buy	538,579 +38,579	+8%	+$225K	0.03%	290
2022 Q3	$3.35M	Sell	500,000 -100,000	-17%	-$670K	0.04%	284
2022 Q2	$2.53M	Buy	600,000 +51,910	+9%	+$219K	0.03%	374
2022 Q1	$1.85M	Hold	548,090	–	–	0.02%	441
2021 Q4	$1.73M	Buy	548,090 +50,000	+10%	+$157K	0.02%	463
2021 Q3	$1.63M	Hold	498,090	–	–	0.02%	528
2021 Q2	$2.1M	Buy	498,090 +150,871	+43%	+$637K	0.02%	503
2021 Q1	$1.73M	Hold	347,219	–	–	0.02%	482
2020 Q4	$4.39M	Sell	347,219 -193,135	-36%	-$2.44M	0.06%	291
2020 Q3	$5.31M	Buy	540,354 +37,571	+7%	+$369K	0.08%	252
2020 Q2	$5M	Buy	502,783 +50,883	+11%	+$506K	0.08%	263
2020 Q1	$4M	Buy	451,900 +133,262	+42%	+$1.18M	0.08%	207
2019 Q4	$2.94M	Buy	+318,638	New	+$2.94M	0.04%	255
2019 Q3	–	Sell	-307,738	Closed	-$3.69M	–	502
2019 Q2	$3.69M	Buy	307,738 +93,369	+44%	+$1.12M	0.05%	251
2019 Q1	$2.59M	Buy	214,369 +119,369	+126%	+$1.44M	0.03%	242
2018 Q4	$1.19M	Buy	+95,000	New	+$1.19M	0.02%	278
2017 Q4	–	Sell	-368,243	Closed	-$5.43M	–	521
2017 Q3	$5.43M	Buy	368,243 +6,576	+2%	+$97K	0.04%	269
2017 Q2	$5.05M	Buy	361,667 +159,595	+79%	+$2.23M	0.04%	268
2017 Q1	$3.45M	Sell	202,072 -154,143	-43%	-$2.63M	0.03%	340
2016 Q4	$3.67M	Buy	356,215 +25,378	+8%	+$261K	0.03%	343
2016 Q3	$3.35M	Buy	+330,837	New	+$3.35M	0.03%	345
2015 Q4	–	Sell	-162,534	Closed	-$3.05M	–	474
2015 Q3	$3.05M	Buy	162,534 +27,273	+20%	+$512K	0.04%	296
2015 Q2	$2.01M	Buy	135,261 +5,261	+4%	+$78.3K	0.02%	331
2015 Q1	$1.97M	Buy	+130,000	New	+$1.97M	0.03%	348
2014 Q4	–	Sell	-102,280	Closed	-$1.29M	–	518
2014 Q3	$1.29M	Sell	102,280 -51,967	-34%	-$655K	0.03%	297
2014 Q2	$1.56M	Sell	154,247 -138,526	-47%	-$1.4M	0.03%	296
2014 Q1	$3.94M	Buy	+292,773	New	+$3.94M	0.11%	178